Rossari Biotech Valuation
| ROSSARI Stock | 817.45 4.50 0.55% |
At this time, the company appears to be overvalued. Rossari Biotech holds a recent Real Value of USD621.26 per share. The prevailing price of the company is USD817.45. Our model determines the value of Rossari Biotech from analyzing the company fundamentals such as Return On Equity of 0.13, shares outstanding of 55.36 M, and Operating Margin of 0.10 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 4.0486 | Enterprise Value 46 B | Enterprise Value Ebitda 17.3067 | Price Sales 2.3566 | Trailing PE 32.6067 |
Overvalued
Today
Please note that Rossari Biotech's price fluctuation is very steady at this time. Calculation of the real value of Rossari Biotech is based on 3 months time horizon. Increasing Rossari Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Rossari Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Rossari Stock. However, Rossari Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 817.45 | Real 621.26 | Hype 817.45 | Naive 816.34 |
The intrinsic value of Rossari Biotech's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Rossari Biotech's stock price.
Estimating the potential upside or downside of Rossari Biotech Limited helps investors to forecast how Rossari stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rossari Biotech more accurately as focusing exclusively on Rossari Biotech's fundamentals will not take into account other important factors: Rossari Biotech Cash |
|
Rossari Biotech Total Value Analysis
Rossari Biotech Limited is at this time forecasted to have takeover price of 45.96 B with market capitalization of 45.35 B, debt of 1.19 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Rossari Biotech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
45.96 B | 45.35 B | 1.19 B |
Rossari Biotech Investor Information
About 68.0% of the company outstanding shares are owned by corporate insiders. The book value of Rossari Biotech was at this time reported as 202.14. The company recorded earning per share (EPS) of 25.07. Rossari Biotech last dividend was issued on the 16th of August 2024. Based on the key indicators obtained from Rossari Biotech's historical financial statements, Rossari Biotech Limited is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 589.9 M | 432.6 M |
|
| |||||
| Operating Income | 4.3 B | 4.1 B |
|
|
Rossari Biotech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Rossari Biotech has an asset utilization ratio of 116.44 percent. This signifies that the Company is making USD1.16 for each dollar of assets. An increasing asset utilization means that Rossari Biotech Limited is more efficient with each dollar of assets it utilizes for everyday operations.Rossari Biotech Ownership Allocation
Rossari Biotech owns a total of 55.36 Million outstanding shares. Rossari Biotech holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 68.18 pct. of Rossari Biotech outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Rossari Biotech Profitability Analysis
The company reported the revenue of 18.31 B. Net Income was 1.31 B with profit before overhead, payroll, taxes, and interest of 3.74 B.About Rossari Biotech Valuation
An absolute valuation paradigm, as applied to Rossari Stock, attempts to find the value of Rossari Biotech based on its fundamental and basic technical indicators. By analyzing Rossari Biotech's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Rossari Biotech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rossari Biotech. We calculate exposure to Rossari Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Rossari Biotech's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 5.3 B | 2.9 B |
Rossari Biotech Quarterly Retained Earnings |
|
Complementary Tools for Rossari Stock analysis
When running Rossari Biotech's price analysis, check to measure Rossari Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rossari Biotech is operating at the current time. Most of Rossari Biotech's value examination focuses on studying past and present price action to predict the probability of Rossari Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rossari Biotech's price. Additionally, you may evaluate how the addition of Rossari Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |